Vincerx Pharma, Inc. (VINC) Misses Q3 EPS by 25c

Vincerx Pharma, Inc. (NASDAQ: VINC) reported Q3 EPS of ($0.80), $0.25 worse than the analyst estimate of ($0.55). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Vincerx Pharma, Inc. (VINC) click here.

You May Also Be Interested In

• EU proposes to curb Airbnb and short-term rentals amid housing shortage
• Lululemon (LULU) PT Lowered to $115 at Freedom Broker
• Ardent Health revises 2025 non-GAAP figures after SEC staff talks